Understand where you stand, what matters most and what to do first — connecting 101 markers and measures with your body, goals, training, nutrition, sleep and routine.
Sam, the headline finding is your LDL Cholesterol at 3.55 mmol/L — above the lab's normal range. LDL is the cholesterol being carried around your bloodstream, and yours is running higher than the cut-off. It's not a number to panic about on its own. It is the one to take to your GP, alongside your family history and any earlier cholesterol readings, to decide whether it's something to watch or something to treat.
The pattern Around that headline, the primary pattern is your lipid profile. Your ApoB (the count of cholesterol-carrying particles), your LDL and your small LDL fraction are all above optimal — one pattern, not three separate findings. Sitting next to that is an omega-3 deficit — your Omega-3 Index and EPA are low, which matters because these fats influence how inflammatory the lipid picture behaves. There's also a mild blood-sugar regulation pattern, and your B-vitamins are lower than ideal — small adjustments should resolve both.
The good news Your inflammation picture is settled — White Blood Cell Count at 5.8 sits mid-range with nothing flaring — and stress and recovery reads well, with Creatine Kinase at 180 showing your 4 hours a week of lifting and running are being absorbed rather than accumulating as damage. Resting pulse of 62 and a BMI of 25.9 confirm the training is doing its job; this panel is about refining a lipid signature on top of a body that's fundamentally working.
Your LDL cholesterol — often called 'bad' cholesterol — is sitting above the reference range. Your lipoprotein(a) and Apolipoprotein E results are both optimal, which is a genuinely reassuring part of the picture.
LDL carries cholesterol particles through the bloodstream, and when levels run persistently elevated, those particles can gradually deposit in artery walls over time. In a meaningful proportion of people this pattern, left unaddressed over years, contributes to cardiovascular risk — though the overall trajectory depends heavily on the full lipid picture and lifestyle context.
This is worth monitoring with your GP on an annual basis to track the trend rather than treat a single snapshot. At age 42, establishing a baseline trajectory now gives you and your doctor the most useful long-term data.
There is no single Tier 1 supplement with a strong direct effect on LDL in isolation, so no foundational supplement applies here — targeted fibre support appears in your Supplements section. This is not an emergency and not a diagnosis — it is a useful early signal to have on file.
Every action below is ranked. Open any card to see why Revi selected it.
Understand where you stand, what matters most and what to do first.
An honest read on each number. Green = optimal · Amber = worth improving · Red = focus here first · Blue = confirm this reading first.
Your exact training, nutrition, supplement and lifestyle protocols — personalised to your baseline. The rhythm holds every day; you train in the evenings, so it anchors sleep, light and meals — swap training days as family life demands.
Projected from your age, biometrics, markers and protocols — grounded in published effect sizes where they exist — the strength varies by marker.
You told us what you want back — here’s when each part shows up. Some of it you’ll feel in weeks. Some you won’t — it just banks, quietly, over decades.
Illustrative sample — fictional client, representative data. Evidence-informed 24-week trajectories — estimates reflect this baseline and published effect ranges; individual responses vary, and the retest shows what actually moved. Ranges are the model’s own where it produced them, otherwise an indicative ±10% band around its central estimate, capped at your current value where the band would cross it. Supplement doses are best agreed with a qualified practitioner — full cautions and retest logistics live in the sections above.
Beetroot extract (nitrate) — conditional, pending data. Establish a 7-day home blood-pressure average first. If your 7-day average is ≥135/85 mmHg (the NICE home threshold), 400–500 mg standardised nitrate daily is a reasonable addition; if readings sit below it, this is not warranted — a supplement held until the data says otherwise.
Creatine monohydrate (optional performance extra) — nothing in your panel asks for it. It is simply the best-evidenced training-performance supplement there is, with emerging cognitive data: 5 g daily, any time.
Anchors, drivers and the ranked plan for each system Revi prioritised.
This system has a big say in long-term cardiovascular health, body composition, and recovery between hard training days. Your resting pulse, Lipoprotein(a), and several protective markers are reassuring — there is a solid foundation here. The main signal is a clear pattern of elevated cholesterol-carrying particles alongside an imbalanced fatty acid profile, most consistent with a dietary composition that is low in marine omega-3s and high in omega-6 sources, compounding a lipid picture that warrants direct action.
This system has a big say in your body composition, energy across the day, and long-term health. All your markers sit within the reference range, which is genuinely reassuring — there is no clinical concern here. What the data does show is one emerging trend across nine markers on the same axis, most consistent with early-stage insulin handling that is drifting in the wrong direction and worth addressing now rather than later.
This system has a big say in your energy, recovery, focus, and long-term health — it governs how efficiently your body produces and recycles the building blocks every cell depends on. Several markers in your iron and mineral panel are sitting in a strong position, which is genuinely reassuring. The main signal is an emerging pattern across folate, Active B12 and homocysteine — all within laboratory reference, all trending in the same direction relative to Revi targets, most consistent with a dietary and lifestyle gap that is well within reach to address.
| Marker | Result | Opt Gap | How to improve it |
|---|---|---|---|
| Red Cell Distribution Width (RDW) Cellular Energy |
14.6 % | 53.3% from optimal | Eat 200 g dark leafy greens (spinach or kale) and 150 g cooked lentils daily to support B12 and folate status, which can drive red cell size variability when suboptimal. The folate-rich foods in your plan support this, and RDW is re-checked at your 24-week retest. |
| Testosterone Hormones |
17 nmol/L | In range — headroom, not a deficit | At 17 nmol/L your testosterone is mid-reference — comfortably above the level where low-T symptoms concentrate, so this is headroom to build rather than a deficit to fix. Later on, progress resistance training to 3 sessions/week (compound lifts at 70–85% 1RM — your single-rep max), extend sleep to 7.5h nightly (fixed 23:00–06:30 window) and keep alcohol ≤4 units/week. Retest fasted before 09:00 at your next panel. |
All 101 markers by system — search or filter to find any result.
| INFLAMMATION & IMMUNE | |||||||
| Biomarker | Unit | Result | Reference Range | Optimal Zone | Status | Opt Gap | Optimisation Tier |
|---|---|---|---|---|---|---|---|
| C-Reactive Protein (hs-CRP)Primary Anchor | mg/l | 1.6 | <5 | <0.5 | Above Optimal Zone | 24.4% from optimal | T3 |
| White Blood Cell CountSecondary Anchor | 10E9-L | 5.8 | 4–10 | 4.5–6 | Optimal | — | |
| Eosinophil Count | 10E9-L | 0.18 | 0.04–0.4 | 0.04–0.3 | Optimal | — | |
| Lymphocyte Count | 10E9-L | 1.9 | 1–3.5 | 1.6–2.6 | Optimal | — | |
| Monocyte Count | 10E9-L | 0.45 | 0.2–0.8 | 0.25–0.55 | Optimal | — | |
| Neutrophil Count | 10E9-L | 3.2 | 2–7.5 | 2–3.5 | Optimal | — | |
| Platelet Count | 10E9-L | 245 | 150–450 | 200–280 | Optimal | — | |
| Basophil Count | 10E9-L | 0.03 | 0.01–0.1 | 0.01–0.06 | Optimal | — | |
| CELLULAR ENERGY | |||||||
| Biomarker | Unit | Result | Reference Range | Optimal Zone | Status | Opt Gap | Optimisation Tier |
| HaemoglobinPrimary Anchor | g/L | 152 | 130–180 | 140–150 | Above Optimal Zone | 6.7% from optimal | |
| Red Blood Cell CountSecondary Anchor | 10E12-L | 4.78 | 4.5–6.5 | 4.6–5.4 | Optimal | — | |
| Mean Cell Haemoglobin | pg | 31.8 | 27–32 | 28.5–30.5 | Above Optimal Zone | 86.7% from optimal | |
| Mean Cell Volume | fl | 97.9 | 76–100 | 85–90 | Above Optimal Zone | 79.0% from optimal | |
| Mean Cell Haemoglobin Concentration (MCHC) | g/L | 325 | 320–360 | 340–355 | Below Optimal Zone | 75.0% from optimal | |
| Red Cell Distribution Width (RDW) | % | 14.6 | 11–16 | 11–13 | Above Optimal Zone | 53.3% from optimal | T2 |
| Haematocrit | % | 46.8 | 40–54 | 42–44 | Above Optimal Zone | 28.0% from optimal | T3 |
| Glutathione Reductase | u/L | 62 | >33 | 56.1–66 | Optimal | — | |
| METABOLIC | |||||||
| Biomarker | Unit | Result | Reference Range | Optimal Zone | Status | Opt Gap | Optimisation Tier |
| InsulinPrimary Anchor | pmol/L | 62.5 | 17.8–173 | 18.1–30 | Above Optimal Zone | 22.7% from optimal | T3 |
| HbA1cSecondary Anchor | mmol/mol | 39 | <42 | <35 | Above Optimal Zone | 57.1% from optimal | T2 |
| Uric Acid | μmol/L | 395 | 200–430 | 240–310 | Above Optimal Zone | 70.8% from optimal | T1 |
| Triglycerides | mmol/L | 1.75 | <2.3 | <1 | Above Optimal Zone | 57.7% from optimal | T2 |
| HDL Cholesterol | mmol/L | 1.25 | >1 | 1.55–2 | Below Optimal Zone | 54.5% from optimal | T2 |
| Adiponectin | Ug/ml | 4.5 | 1.44–7.27 | 5.52–7.27 | Below Optimal Zone | 25.0% from optimal | T3 |
| WHtR | ratio | 0.51 | <0.55 | <0.5 | Above Optimal Zone | 22.0% from optimal | T2 |
| C-Peptide | ng/ml | 2.1 | 1.1–4.4 | 1.1–1.5 | Above Optimal Zone | 20.7% from optimal | T3 |
| Glucose | mmol/L | 5.4 | 4–7 | 4.6–5 | Above Optimal Zone | 20.0% from optimal | |
| BMI | kg/m² | 25.9 | 18.5–29.9 | 20–24.9 | Above Optimal Zone | 20.0% from optimal | T2 |
| STRESS & RECOVERY | |||||||
| Biomarker | Unit | Result | Reference Range | Optimal Zone | Status | Opt Gap | Optimisation Tier |
| CortisolPrimary Anchor | nmol/l | 495 | 138–690 | 250–450 | Above Optimal Zone | 18.8% from optimal | |
| Creatine Kinase (CK)Secondary Anchor | u/l | 180 | 39–308 | 40–200 | Optimal | — | |
| Lactate Dehydrogenase | U/L | 330 | 230–460 | 250–350 | Optimal | — | |
| HORMONES | |||||||
| Biomarker | Unit | Result | Reference Range | Optimal Zone | Status | Opt Gap | Optimisation Tier |
| Thyroid Stimulating Hormone (TSH)Primary Anchor | mIU/L | 1.8 | 0.35–5.5 | 1–2.5 | Optimal | — | |
| Free Androgen Index (FAI)Secondary Anchor | % | 53.1 | 35–92.6 | 40–80 | Optimal | — | |
| Free Testosterone | pmol/L | 346 | 210–580 | 469–580 | Below Optimal Zone | 47.5% from optimal | T2 |
| Testosterone | nmol/L | 17 | 8.64–29 | 22.89–29 | Below Optimal Zone | 41.3% from optimal | T2 |
| IGF-1 (Insulin-like Growth Factor 1) | nmol/L | 22 | 8.2–29.2 | 14–20 | Above Optimal Zone | 21.7% from optimal | T3 |
| Free Thyroxine (FT4) | pmol/L | 15.8 | 11.9–21.6 | 12–15.5 | Above Optimal Zone | 4.9% from optimal | |
| Estradiol | pmol/l | 95 | 41.4–159 | 70–150 | Optimal | — | |
| Progesterone | nmol/L | 0.3 | <0.47 | <0.3 | Optimal | — | |
| DHEA-S | μmol/l | 7.8 | 2.4–11.6 | 5–9 | Optimal | — | |
| SHBG | nmol/L | 32 | 18.3–54.1 | 25–45 | Optimal | — | |
| Anti-Thyroid Peroxidase Antibody | ku/L | 12 | <34 | <15 | Optimal | — | |
| Anti-Thyroglobulin Antibody | IU/ml | 15 | <115 | <40 | Optimal | — | |
| Free Tri-iodothyronine (FT3) | pmol/L | 4.9 | 3.1–6.8 | 4–5.8 | Optimal | — | |
| Parathyroid Hormone (PTH) | pmol/L | 3.8 | 1.6–6.9 | 2.5–4.5 | Optimal | — | |
| FSH (Follicle Stimulating Hormone) | U/L | 4.2 | 1.5–12.4 | 2.5–7 | Optimal | — | |
| LH (Luteinising Hormone) | U/L | 4.8 | 1.7–8.6 | 2–7 | Optimal | — | |
| LIPID & HEART | |||||||
| Biomarker | Unit | Result | Reference Range | Optimal Zone | Status | Opt Gap | Optimisation Tier |
| Apolipoprotein BPrimary Anchor | mg/dl | 105 | 49–173 | 49–60 | Above Optimal Zone | 39.8% from optimal | T3 |
| Small LDL CholesterolSecondary Anchor | mg/dl | 52 | <60.8 | <20 | Above Optimal Zone | 78.4% from optimal | T1 |
| LDL Cholesterol | mmol/L | 3.55 | <3 | <1.8 | GP Flag (Tier 2) | 18.3% above the reference range | |
| Total Cholesterol | mmol/L | 5.6 | <5 | <4 | Outside Ref | 12.0% above the reference range | T1 |
| Omega-6 / Omega-3 Ratio | - | 7.5 | 3.09–5.11 | 3.09–3.7 | Outside Ref | 46.8% above the reference range | T1 |
| AA:EPA Ratio | - | 18.3 | 2.49–11.11 | 2.49–3 | Outside Ref | 64.7% above the reference range | T1 |
| Omega-3 Index | % | 4.6 | 4–12.01 | 10–12.01 | Below Optimal Zone | 90.0% from optimal | T1 |
| Apolipoprotein B / A-I Ratio | Ratio | 0.89 | <1 | <0.6 | Above Optimal Zone | 72.5% from optimal | |
| Apolipoprotein A-I | mg/dl | 118 | 104–202 | 150–201 | Below Optimal Zone | 69.6% from optimal | T1 |
| Total Cholesterol / HDL Ratio | Ratio | 4.48 | <5 | <3.5 | Above Optimal Zone | 65.3% from optimal | |
| EPA | % | 0.9 | 0.25–4.5 | 1.5–4.5 | Below Optimal Zone | 48.0% from optimal | T2 |
| BP Clinic Systolic | mmHg | 128 | 90–139 | <119 | Above Optimal Zone | 45.0% from optimal | T2 |
| Trans Fat Index | % | 0.7 | <1.01 | <0.5 | Above Optimal Zone | 39.2% from optimal | T3 |
| BP Clinic Diastolic | mmHg | 82 | 60–89 | <79 | Above Optimal Zone | 30.0% from optimal | T2 |
| AA (Arachidonic Acid) | % | 16.5 | 9.81–18.32 | 12.36–15.77 | Above Optimal Zone | 28.6% from optimal | T3 |
| Apolipoprotein CIII | mg/dl | 9.5 | 4.5–18 | 4.5–8.55 | Above Optimal Zone | 10.1% from optimal | |
| Apolipoprotein CII | mg/dl | 4.2 | 1.68–9.17 | 1.68–3.93 | Above Optimal Zone | 5.2% from optimal | |
| Lipoprotein (a) | nmol/L | 18 | <75 | <75 | Optimal | — | |
| Apolipoprotein E | mg/dl | 4.1 | 2.2–7.3 | 3.73–5.77 | Optimal | — | |
| Resting Pulse | bpm | 62 | 60–100 | 50–70 | Optimal | — | |
| LIVER & DETOX | |||||||
| Biomarker | Unit | Result | Reference Range | Optimal Zone | Status | Opt Gap | Optimisation Tier |
| Alanine Aminotransferase (ALT)Primary Anchor | u/L | 33 | <55 | 10–22 | Above Optimal Zone | 33.3% from optimal | T3 |
| Gamma-Glutamyl Transferase (GGT)Secondary Anchor | u/L | 31 | 10–71 | <25 | Above Optimal Zone | 13.0% from optimal | |
| Aspartate Aminotransferase (AST) | u/L | 26 | <40 | 13–22 | Above Optimal Zone | 22.2% from optimal | T3 |
| Alkaline Phosphatase | u/L | 68 | 30–120 | 40–85 | Optimal | — | |
| Total Bilirubin | μmol/L | 10 | <21 | 8–20 | Optimal | — | |
| Albumin | g/l | 45 | 35–50 | 45–50 | Optimal | — | |
| NUTRIENT | |||||||
| Biomarker | Unit | Result | Reference Range | Optimal Zone | Status | Opt Gap | Optimisation Tier |
| Vitamin D | nmol/L | 55 | 50–375 | 100–150 | Below Optimal Zone | 90.0% from optimal | T1 |
| Magnesium | mmol/L | 0.74 | 0.7–1.1 | 0.85–0.95 | Below Optimal Zone | 73.3% from optimal | T1 |
| Zinc | μmol/L | 13.5 | 11.1–19.5 | 15–20 | Below Optimal Zone | 38.5% from optimal | T3 |
| Homocysteine | μmol/L | 11.5 | 5–20 | 5–8 | Above Optimal Zone | 29.2% from optimal | T3 |
| Folate | μg/l | 12 | 3–26.8 | 15–26.8 | Below Optimal Zone | 25.0% from optimal | T3 |
| Active B12 | pmol/l | 85 | 25.1–165 | 100–165 | Below Optimal Zone | 20.0% from optimal | T3 |
| Transferrin Saturation | % | 31.7 | 20–50 | 24–40 | Optimal | — | |
| Copper | µmol/l | 16 | 11–24 | 14–19 | Optimal | — | |
| Transferrin | g/L | 2.7 | 2–3.8 | 2–3 | Optimal | — | |
| Total Iron Binding Capacity (TIBC) | μmol/L | 60 | 44.8–80.6 | 45–70 | Optimal | — | |
| Iron | umol/L | 19 | 5.8–34.5 | 14.41–25.89 | Optimal | — | |
| Ferritin | μg/l | 120 | 20–300 | 50–150 | Optimal | — | |
| SAFETY & CONTEXT | |||||||
| Biomarker | Unit | Result | Reference Range | Optimal Zone | Status | Opt Gap | Optimisation Tier |
| Bilirubin (Urinalysis) | mg/dl | Negative | — | — | Optimal | — | |
| Ketones | mg/dl | Negative | — | — | Optimal | — | |
| Nitrite | mg/dl | Negative | — | — | Optimal | — | |
| Protein (Urine) | mg/dl | Negative | — | — | Optimal | — | |
| Red Blood Cells (Urine) | rbc/µl | Negative | — | — | Optimal | — | |
| Urobilinogen | mg/dl | 0.2 | — | — | Optimal | — | |
| White Blood Cells (Urine) | leuk/µl | Negative | — | — | Optimal | — | |
| Creatinine | µmol/L | 88 | 64–104 | 70–100 | Optimal | — | |
| Potassium | mmol/L | 4.4 | 3.5–5.3 | 4–4.7 | Optimal | — | |
| eGFR | ml/min | 92 | >60 | 80–110 | Optimal | — | |
| Cystatin C | mg/l | 0.85 | 0.57–1.05 | 0.57–0.85 | Optimal | — | |
| Calcium (Adjusted) | mmol/L | 2.38 | 2.2–2.6 | 2.25–2.45 | Optimal | — | |
| pH | ph | 6.5 | 5–7.5 | 6–7 | Optimal | — | |
| Total Prostate Specific Antigen (PSA) | µg/L | 0.7 | <1.4 | <1 | Optimal | — | |
| Phosphate | mmol/L | 1.1 | 0.8–1.5 | 0.85–1.15 | Optimal | — | |
| Sodium | mmol/L | 140 | 133–146 | 138–142 | Optimal | — | |
| Chloride | mmol/l | 102 | 95–108 | 100–106 | Optimal | — | |
| Urea | mmol/L | 5.2 | 2.5–7.8 | 3.5–6.5 | Optimal | — | |
The plan above runs for 24 weeks. The retest shows what moved.
One comprehensive draw. Your connected analysis, ranked priorities, exact programme and one-to-one review.
Start your Revi assessment →